Drug intelligence / Profile preview

yanreqing granule

Development stage: Unknown
Lead developer: Shandong Wohua Pharmaceutical
Administration: Oral

Overview

Yanreqing Granule is a traditional Chinese medicine (TCM) product developed and marketed by Shandong Wohua Pharmaceutical. It is an oral granule formulation indicated for the treatment of fever and inflammatory conditions, specifically targeting symptoms such as dry throat and sore throat. As a complex herbal preparation, it functions through the synergistic effects of its constituent botanical extracts to clear heat and detoxify. The drug is part of Shandong Wohua's approved portfolio of TCM products in China and is used for its antipyretic and anti-inflammatory properties.

Brand names: Yanreqing Granule炎热清颗粒
Other names: Yanreqing Keli

Beyond the preview

Go deeper on yanreqing granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on yanreqing granule.

Explore the full profile